TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Team Select Home Care says its CareSight AI platform now covers all its patients through three clinical risk models. Company data show hospitalization rates fell 14.9% year over year between April and August 2026, but the figures have not been independently verified in the source report.
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census, and reports that its hospitalization rate fell 14.9% year over year from April through August 2026. The Phoenix-based provider shared the company’s data with Home Health Care News; the result is not presented as an independently verified study.
CareSight uses machine learning trained on more than a decade of Team Select patient records. The platform monitors as many as eight vital signs, along with nurse notes and changes in a patient’s condition, to flag patterns that could signal clinical decline. Team Select serves medically complex children and seniors at home and operates in 16 states.
The company developed three models covering respiratory conditions, cardiac conditions and infection risk. Team Select President and CEO Fred Johnson told Home Health Care News that respiratory was the initial focus because the company had experience with high-acuity care. The respiratory model took three years to develop; the cardiac model took six months, and the infection model took about 90 days. The company says every patient is now covered by at least one model.
The reported outcome compares April–August 2026 with the same months in 2025. Johnson said the 14.9% reduction builds on what he described as Team Select’s already low hospitalization rate. He cited a seven-state Medicaid claims study commissioned by the company that found its monthly 30-day hospitalization rate before CareSight ranged from 3% to 8%, compared with an industry average of 10% to 20% per month. Those figures and the newer outcome are reported by the company, rather than independently validated in the source material.
Hospital Outcomes Could Shape Payer Deals
The reported reduction could strengthen Team Select’s case for value-based contracts, where payment can depend on measures such as hospital use and total cost of care, rather than only on the volume of services. Johnson said the company expects CareSight’s outcome data to support contract growth as providers face difficulty securing higher fee-for-service rates.
For patients and families, the company’s stated aim is to identify deterioration early enough for care teams to respond at home when appropriate. The source does not establish how much of the reported decrease was caused by CareSight, or whether the change led to better outcomes across all patient groups. The figures therefore offer a company-reported signal, not proof that the platform alone produced the reduction.
Broader payer access to consistent results could also affect how home-care providers demonstrate performance. Team Select says it is redeveloping payer scorecards to show measures such as hospitalization and emergency department visit ratios for a payer’s own patients, alongside patient feedback and industry comparisons.
As an affiliate, we earn on qualifying purchases.
From Respiratory Alerts to Census Coverage
Team Select launched CareSight in 2025 after investing, according to the report, $6 million in the platform. The original respiratory model did not cover every diagnosis. Company leaders used hospitalization patterns to select additional areas to address, expanding first to cardiac risk and then to infection detection.
The company also adjusted how the system generates alerts. Johnson said early versions produced too many false positives, including alerts for readings outside general ranges that were normal for a particular patient. Team Select added a patient-specific model that compares readings with each person’s historical baseline. That approach is intended to reduce unnecessary notifications to clinicians; the source does not provide a measured false-alert reduction.
Team Select’s move comes as it looks to use data from its clinical operations in payer negotiations. Court Square Capital Partners invested in the company in 2023. Johnson described the platform as a competitive advantage, citing the company’s integrated records and long-running data history. That assessment is his view, not an independently established comparison with competitors.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select Home Care president and CEO, speaking to Home Health Care News
remote patient vital signs monitor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How Much Did CareSight Contribute?
The source report does not provide a controlled comparison, patient counts, confidence intervals or a breakdown by diagnosis for the 14.9% year-over-year decline. It is not clear whether other changes in staffing, patient mix, clinical practice or access to care affected the result. Nor does the material specify whether the rate refers to admissions per patient, a share of patients hospitalized or another calculation.
The baseline figures cited by Johnson come from a seven-state Medicaid claims study commissioned by Team Select, but the report does not supply the study’s methods or full results. It also remains unclear whether the reduction persisted after August 2026, how the three models perform separately, and whether the claimed decline corresponds to lower emergency visits, costs or other patient outcomes.
medical alert and risk assessment tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Fourth Model Targets Diabetes
Team Select is developing a fourth CareSight model focused on diabetes, according to the report. The company has not provided a launch date or details about the model’s design, patient coverage or evaluation plan.
The provider also plans to continue expanding value-based contracting and is redeveloping payer scorecards, Johnson said. Further outcome reporting would help clarify whether the hospitalization change continues, how results vary across patient groups, and what role CareSight plays alongside other clinical interventions.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did Team Select report?
Team Select said CareSight AI now covers all patients in its census and that hospitalization rates fell 14.9% year over year between April and August 2026. The figures are company data shared with Home Health Care News.
What does CareSight AI monitor?
The platform can monitor up to eight vital signs, as well as nurse notes and changes in condition. Its models address respiratory, cardiac and infection-related risks, according to the report.
Has the 14.9% reduction been independently verified?
The source report attributes the result to Team Select’s data. It does not describe an independent audit or a controlled study establishing that CareSight caused the decline.
What is Team Select developing next?
Team Select is building a fourth model focused on diabetes. The company has not announced a release date in the source material.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
